PMC9334565_01
Overview case presentation. TDM, therapeutic drug monitoring; HAMD, Hamilton depression rating scale; PGx, pharmagocenetic.
fpsyt-13-942268-g001.jpg
PMC9334565_01_fpsyt-13-942268-g001.jpg
F1
At clinic entry, the patient was under treatment with a combination of low-dose trimipramine (50 mg/d) for sleep promotion, and fluoxetine (40 mg/d) for depression, which was established 3 months earlier by an outpatient psychiatrist (Figure 1).